Mycronic AB/Skr MYCR
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Mycronic AB
Mycronic AB is a Swedish company that operates in the electronics manufacturing sector. It specializes in developing and producing high-precision equipment for the electronics industry, particularly focusing on photomask writers, which are essential in the production of displays and semiconductors. The company's product portfolio includes surface mount technology equipment, assembly automation solutions, and inspection systems. Headquartered in Täby, Sweden, Mycronic serves a global market, providing critical tools to manufacturers of electronic components. Its strategic strength lies in its specialization in high-precision and high-mix production environments, meeting the specific needs of varied electronics manufacturers.
- Ticker
- Skr MYCR
- Sector
- Digital Hardware
- Primary listing
- XSTO
- Employees
- 2,875
- Headquarters
- Täby, Sweden
- Website
- www.mycronic.com
Mycronic AB Metrics
BasicAdvanced
kr 59B
29.66
kr 10.19
0.63
kr 3.25
1.08%
Price and volume
Market cap
kr 59B
Beta
0.63
52-week high
kr 364.40
52-week low
kr 183.32
Average daily volume
305K
Dividend rate
kr 3.25
Financial strength
Current ratio
2.284
Quick ratio
1.549
Long term debt to equity
0.034
Total debt to equity
0.049
Dividend payout ratio (TTM)
31.96%
Interest coverage (TTM)
51.60%
Profitability
EBITDA (TTM)
2,962
Gross margin (TTM)
54.88%
Net profit margin (TTM)
21.40%
Operating margin (TTM)
29.42%
Effective tax rate (TTM)
22.37%
Revenue per employee (TTM)
kr 3,230,000
Management effectiveness
Return on assets (TTM)
14.33%
Return on equity (TTM)
25.74%
Valuation
Price to earnings (TTM)
29.658
Price to revenue (TTM)
6.347
Price to book
6.91
Price to tangible book (TTM)
12.75
Price to free cash flow (TTM)
27.318
Free cash flow yield (TTM)
3.66%
Free cash flow per share (TTM)
11.062
Dividend yield (TTM)
1.08%
Forward dividend yield
1.08%
Growth
Revenue change (TTM)
16.58%
Earnings per share change (TTM)
14.23%
3-year revenue growth (CAGR)
21.10%
10-year revenue growth (CAGR)
17.06%
3-year earnings per share growth (CAGR)
39.30%
10-year earnings per share growth (CAGR)
16.98%
3-year dividend per share growth (CAGR)
22.92%
10-year dividend per share growth (CAGR)
15.79%
What the Analysts think about Mycronic AB
Analyst ratings (Buy, Hold, Sell) for Mycronic AB stock.
Analyst projections of the future price of Mycronic AB stock.
Bulls say / Bears say
Second-quarter order intake hit a record SEK 2.92 billion, sales rose 17% and the EBIT margin reached 29%. Mycronic raised its 2026 sales outlook to SEK 9.25 billion, giving a strong near-term growth signal. (Mycronic)
Demand for equipment used in advanced server-board production and optical communications remained strong, with AI data-centre investment supporting Mycronic’s Global Technologies division. This gives the company growth exposure beyond its photomask business. (Mycronic)
Mycronic continues to win semiconductor mask-writer orders, including a recent US order for two SLX systems worth USD 14–16 million. Repeated customer orders support the case for ongoing capacity expansion and replacement demand in this product line. (Mycronic)
The standard industrial market remains weak, particularly in Europe, and PCB Assembly Solutions is undergoing a restructuring to restore its margin above 10% by the end of 2027. The programme is expected to cost SEK 100 million through 2027. (Mycronic)
Some of the quarter’s strong mask-writer intake may not be repeatable: Mycronic said the higher-priced customized SLX order was a one-off, while photomask markets were stable. That makes it risky to extrapolate the quarter’s order growth directly. (Mycronic)
Several banks downgraded Mycronic to Hold after the share-price rally, arguing that short-term momentum was already reflected in the valuation and that visibility on 2027 earnings remained limited. A high starting valuation could leave less room for disappointment-free growth. (MarketScreener)
Data summarised monthly by Lightyear AI. Last updated on 15 Oct 2026.
Mycronic AB Financial Performance
Revenues and expenses
Mycronic AB Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Mycronic AB
AllEURUSDGBP
Fund name | Fund size | Skr MYCR weighting |
|---|---|---|
iShares STOXX Europe 600 Technology€STEC | €26M | 0.52% |
iShares STOXX Europe 600 Technology€EXV3 | €224M | 0.52% |
Xtrackers MSCI Europe Small Cap£XXSC | $3.6B | 0.35% |
Xtrackers MSCI Europe Small Cap€DX2J | $3.6B | 0.35% |
Vanguard ESG Developed Europe All Cap£V3EA | €125M | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.